Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells

HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cells

US Patent 8518914 · Granted Aug 27, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tire comprising a textured tread2024
Composition and methods used during anti-HIV treatment2017
Composition and methods used during anti-HIV treatment2017
Method for analyzing D4Z4 tandem repeat arrays of nucleic acid and kit therefore2016
Combination of an HMG-CoA reductase inhibitor and a farnesyl-pyrophosphate synth2015
Combination of an HMG-CoA reductase inhibitor and a farnesyl-pyrophosphate synth2015
Combination of an HMG-CoA reductase inhibitor and a farnesyl-pyrophosphate synth2015
Suspension system for vehicle and tire for vehicle2015
Exon skipping therapy for dysferlinopathies2013
Human cathepsin L2 protein, gene encoding said protein and use thereof2004